Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT
|
BSE: 524742
|
ISIN: INE475E01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
1946.1000
-1.80
(
-0.09
%)
NSE
Nov 12, 2025
15:31 PM
26.31% Fall from 52W High
Volume:
69,728
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Caplin Point Laboratories Ltd.
13 Nov 2022, 12:00AM
1946.10
-0.09%
Caplin Point Laboratories
Buy:
Caplin Point Laboratories ...
by
ICICI Direct
Target: 955
Target
ICICI Direct
ICICI Direct decreased Buy price target of Caplin Point Laboratories Ltd. to 2295.0 on 10 Nov, 2025.
More from Caplin Point Laboratories Ltd.
Recommended
Market closes higher, Adani Enterprises announces Rs 24,930 crore rights issue
Trendlyne Marketwatch |
12 Nov 2025, 04:11PM
Retail investors have driven an IPO boom in 2025
The Baseline |
12 Nov 2025, 12:42PM
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
|
01 Jul 2022